KYLYS AESTHETICS SA is an early-stage Biopharmaceutical Company revolutionizing skin filling science.

Enhancing aesthetic safety and precision through our next generation Hyaluronic Acid-based dermal fillers, designed to minimize post-injection side effects and maximize comfort.


KYLYS AESTHETICS SA offers a biocompatible hyaluronan-based dermal filler that is highly injectable and has the ability to form microgel structures in the tissue, resulting in a long-lasting effect and no migration from the injection site. Our patented technology allows for injection with an ultra-thin 34G needle, resulting in greater precision, less pain for the patient, and fewer hematomas. With our cutting-edge technology and commitment to research and development, we aim to revolutionize the market.

Our Technology

KYLYS AESTHETICS’ technology enables customization of specific properties tailored to each product’s application.

Our Team

Bryan Porcello


Having founded and led two companies, I bring a proven track record in startups. My educational background includes a BSc in Management and an MSc in Finance from HEC Lausanne, complemented by a CFA certification. My experience in corporate banking has equipped me with advanced skills in financial management and risk analysis.

Dr. Alexandre Porcello


With a Ph.D. in pharmaceutical technology and expertise in KYLYS AESTHETICS since 2019, I specialize in hyaluronic acid and biopolymers, excel in clean room fabrication, and have advanced innovation management skills from Sitem’s MAS program, successfully commercializing luxury cosmetics and wellness brands.

Dr. Pascal Bordat

Strategic Development

With over 30 years of product development experience in companies like Estee Lauder, Pierre Fabre, and Johnson & Johnson, I led Strategic Development at HTL Biotechnology from 2014 to 2019. Subsequently, I served as Chief Innovation Officer and Head of the HTL incubator from 2020 to 2022.